Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Prophylaxis for Febrile Neutropenia in Pediatric ALL
NCT07320534Phase 4Terminated
- Sponsor
- Universitas Gadjah Mada
- Start
- Jan 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in febrile neutropenia (FN), sponsored by Universitas Gadjah Mada. Started Jan 2026; status: terminated.
02
Drugs
levofloxacin
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT07320534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07320534.